Delivery Order SPE2DR25D3015-SPE2DR26F4FE5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $5,700.75 and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $5,898.94. This firm fixed-price delivery order is scheduled for ultimate completion by September 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $1,259.13. This firm fixed-price delivery order, which has an ultimate completion date of November 13, 2025, is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the agency's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $4,508.52. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside contract vehicle, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,562.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $15,561.58. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $4,392.89. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Progesterone 200 mg capsules (100-count units) valued at $5,087.94 with firm fixed pricing. This non-competitive delivery order is set to conclude on September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FE5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $5,986.37. This is a firm fixed-price delivery order with an ultimate completion date of December 8, 2025, and no set-aside designation was used. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a major pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a primary pharmaceutical vendor, consistently delivering competitively awarded contracts for both brand-name and generic medications across multiple therapeutic domains to support Department of Defense and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 12/4/25 |